摘要
目的:评价磷酸化表皮生长因子受体(phosphorylated epidermal growth factor receptor,p-EGFR)及其信号转导通路下游分子AKT的活化形式磷酸化AKT(phosphorylated AKT,p-AKT)在非小细胞肺癌(non-small cell lung cancer,NSCLC)组织中的表达及其意义。方法:免疫组织化学法检测95例NSCLC组织中p-AKT和p-EGFR蛋白的表达,并分析2种蛋白表达之间的关系及与预后的相关性。结果:p-EGFR的阳性表达率为57.89%(55/95),在低年龄组(33/46)、女性组(24/30)和腺癌组(35/52)的表达率较高,差异有统计学意义(P=0.008,P=0.003,P=0.009)。p-AKT的阳性表达率为66.32%(63/95),在低分化组(20/23)、有淋巴结转移组(29/37)和肿瘤较小(≤3cm)组(36/46)的表达率较高,差异有统计学意义(P=0.036,P=0.047,P=0.017)。单因素分析显示,p-AKT和p-EGFR蛋白表达与预后无关(P=0.854,P=0.729)。多因素分析显示,2种蛋白表达与生存时间也无关(P=0.497,P=0.731)。p-AKT表达与p-EGFR表达呈正相关性(r=0.204,P=0.047)。结论:p-EGFR和p-AKT的阳性表达率对NSCLC患者预后无提示意义,二者均不能成为预后指标。
Objective:To evaluate the expressions of phosphorylated epidermal growth factor receptor(p-EGFR) and its downstream molecule phosphorylated AKT(p-AKT) in non-small cell lung cancer(NSCLC)and their significance.Methods:The immunhistochemistry was used to detect the expressions of p-AKT and p-EGFR proteins in 95 cases of NSCLC tissues.The relationship between the p-AKT and p-EGFR and between their expression and prognosis were also evaluated.Results:The positive rate of p-EGFR was 57.89%(55/95) and was related with age,gender and histological type(P=0.008,P=0.003,P=0.009).The positivity of p-EGFR was higher in young group(33/46),female group(24/30),and adenocarcinoma group(35/52).The positive rate of p-AKT was 66.32%(63/95) and was related with differentiation,lymph node metastasis and tumor size(P=0.036,P=0.047,P=0.017,res-pectively).The positivity of p-AKT was higher in low differentiation group(20/23),lymph node metastasis group(29/37),and tumor diameter ≤3 cm group(36/46).Univariate analysis showed that the expressions of p-AKT and p-EGFR were not associated with prognosis(P=0.854,P=0.729).Multivariate analysis showed that neither p-AKT nor p-EGFR was correlated with the patients' survival time(P=0.497,P=0.731).The p-AKT was positively correlated to the p-EGFR(r=0.204,P=0.047).Conclusion:The expressions of p-AKT and p-EGFR had no impact on the prognosis of NSCLC.They can not serve as prognostic indicators for NSCLC.
出处
《肿瘤》
CAS
CSCD
北大核心
2010年第4期328-333,共6页
Tumor
基金
上海市卫生局科研课题计划项目(编号:054014)
关键词
癌
非小细胞肺
原癌基因蛋白质c-AKT
受体
表皮生长因子
磷酸化
预后
Carcinoma
non-small cell lung
Proto-oncogene proteins c-AKT
Receptor
epidermal growth factor
Phosphorylation
Prognosis